DRUG · Unmapped registry intervention
HB1801
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of HB1801 Versus Docetaxel (Taxotere®) in Patients With Advanced Breast Cancer
NCT07805135
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Docetaxel (Taxotere®)
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of HB1801 Versus Docetaxel (Taxotere®) in Patients With Advanced Breast Cancer
Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HER2-Negative Advanced Breast Cancerunresolved
Interventions
HB1801DRUG
Sponsors & collaborators
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.lead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07805135 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.